Cite

    A. Ningombam et al.. “Addition of oral fexofenadine to topical therapy leads to a significantly greater reduction in the serum interleukin‐31 levels in mild to moderate paediatric atopic dermatitis.” Clinical and experimental dermatology, vol. 47, 2022, pp. 724–729. http://access.bl.uk/ark:/81055/vdc_100176520940.0x000030